Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Katsushige Kawase"'
Autor:
Wenhao Zhou, Shusuke Kawashima, Takamasa Ishino, Katsushige Kawase, Youki Ueda, Kazuo Yamashita, Tomofumi Watanabe, Masahito Kawazu, Hiromichi Dansako, Yutaka Suzuki, Hiroyoshi Nishikawa, Takashi Inozume, Joji Nagasaki, Yosuke Togashi
Publikováno v:
Cell Reports, Vol 43, Iss 2, Pp 113797- (2024)
Summary: Immune checkpoint inhibitors exert clinical efficacy against various types of cancer through reinvigoration of exhausted CD8+ T cells that attack cancer cells directly in the tumor microenvironment (TME). Using single-cell sequencing and mou
Externí odkaz:
https://doaj.org/article/a16afc6c6d2a44839375efb4ad0cb6e6
Autor:
Shinichi Namba, Toshihide Ueno, Shinya Kojima, Kenya Kobayashi, Katsushige Kawase, Yosuke Tanaka, Satoshi Inoue, Fumishi Kishigami, Shusuke Kawashima, Noriko Maeda, Tomoko Ogawa, Shoichi Hazama, Yosuke Togashi, Mizuo Ando, Yuichi Shiraishi, Hiroyuki Mano, Masahito Kawazu
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-16 (2021)
Namba et al develop a new pipeline called MuSTA to enable the efficient assembly of transcriptome from long-read sequencing data of breast cancer samples. This method enables the authors to discover subtype-specific isoforms, find that fusion transcr
Externí odkaz:
https://doaj.org/article/fed8f30c93874058b219cc151c3f2be3
Autor:
Fumiaki Mukohara, Kazuma Iwata, Takamasa Ishino, Takashi Inozume, Joji Nagasaki, Youki Ueda, Ken Suzawa, Toshihide Ueno, Hideki Ikeda, Katsushige Kawase, Yuka Saeki, Shusuke Kawashima, Kazuo Yamashita, Yu Kawahara, Yasuhiro Nakamura, Akiko Honobe-Tabuchi, Hiroko Watanabe, Hiromichi Dansako, Tatsuyoshi Kawamura, Yutaka Suzuki
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; 8/27/2024, Vol. 121 Issue 35, p1-40, 51p
Autor:
Katsushige Kawase, Shusuke Kawashima, Joji Nagasaki, Takashi Inozume, Etsuko Tanji, Masahito Kawazu, Toyoyuki Hanazawa, Yosuke Togashi
Publikováno v:
Cancer Immunology Research. :OF1-OF14
IFNγ signaling pathway defects are well-known mechanisms of resistance to immune checkpoint inhibitors. However, conflicting data have been reported, and the detailed mechanisms remain unclear. In this study, we have demonstrated that resistance to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cee780fdb1a79ff5870b9e703a01949d
https://doi.org/10.1158/2326-6066.cir-22-0815
https://doi.org/10.1158/2326-6066.cir-22-0815
Autor:
Yosuke Togashi, Toyoyuki Hanazawa, Masahito Kawazu, Etsuko Tanji, Takashi Inozume, Joji Nagasaki, Shusuke Kawashima, Katsushige Kawase
Supplementary Figure S1-S7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11509e084f8d341e35fbc028e0648cf6
https://doi.org/10.1158/2326-6066.22640286
https://doi.org/10.1158/2326-6066.22640286
Autor:
Yosuke Togashi, Toyoyuki Hanazawa, Masahito Kawazu, Etsuko Tanji, Takashi Inozume, Joji Nagasaki, Shusuke Kawashima, Katsushige Kawase
IFNγ signaling pathway defects are well-known mechanisms of resistance to immune checkpoint inhibitors. However, conflicting data have been reported, and the detailed mechanisms remain unclear. In this study, we have demonstrated that resistance to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d0505ac2db150b4083d6618341a3b06
https://doi.org/10.1158/2326-6066.c.6601461.v1
https://doi.org/10.1158/2326-6066.c.6601461.v1
Autor:
Yosuke Togashi, Toyoyuki Hanazawa, Masahito Kawazu, Etsuko Tanji, Takashi Inozume, Joji Nagasaki, Shusuke Kawashima, Katsushige Kawase
Supplementary Table S1-S9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcceb78a5df2c4d59e278071265504a1
https://doi.org/10.1158/2326-6066.22640283.v1
https://doi.org/10.1158/2326-6066.22640283.v1
Autor:
Katsushige Kawase, Shusuke Kawashima, Joji Nagasaki, Takashi Inozume, Hiromasa Yamamoto, Masahito Kawazu, Toyoyuki Hanazawa, Yosuke Togashi
Publikováno v:
Cancer Research. 83:707-707
IFN-γ signaling pathway defects such as JAK mutations are well-known mechanisms of resistance to immune checkpoint inhibitors (ICIs). However, some patients respond to ICIs despite IFN-γ signaling pathway defects, and the detailed mechanisms remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d4419dc135c039fbc0f20229b22354f
https://doi.org/10.1158/1538-7445.am2023-707
https://doi.org/10.1158/1538-7445.am2023-707
Autor:
Keiichi Koshizuka, Riyo Yoneda, Katsushige Kawase, Toyoyuki Hanazawa, Kazuki Yamasaki, Syuji Yonekura
Publikováno v:
Toukeibu Gan. 47:284-289
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b47b467fba5cd34c6ecc39d089df91a8
https://doi.org/10.5981/jjhnc.47.284
https://doi.org/10.5981/jjhnc.47.284
Autor:
Takashi Inozume, Yutaka Suzuki, Toshihide Ueno, Tatsuyoshi Kawamura, Nishikawa Hiroyoshi, Hiroyuki Mano, Kazuo Yamashita, Masayuki Hino, Yosuke Togashi, Hiroyuki Matsue, Mitsuru Yoshino, Katsushige Kawase, Ryo Ariyasu, Etsuko Tanji, Toyoyuki Hanazawa, Akiko Honobe, Joji Nagasaki, Vitaly Kochin, Keita Sasaki, Takehiro Ohnuma, Nirolas Sax, Masahito Kawazu, Takuma Irie, Takekazu Iwata
Publikováno v:
SSRN Electronic Journal.
PD-1 blockade exerts clinical efficacy against various types of cancer by reinvigorating T cells that directly attack tumor cells (tumor-specific T cells) in the tumor microenvironment (TME), and tumor-infiltrating lymphocytes (TILs) also comprise no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::879639c4620fd6a12240d2ab79580ea3
https://doi.org/10.2139/ssrn.3796528
https://doi.org/10.2139/ssrn.3796528